Nuo Therapeutics, Inc.
AURX
$1.24
$0.010.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.47% | 6.97% | -20.29% | -5.26% | 23.96% |
| Total Depreciation and Amortization | 49.30% | 100.98% | 104.52% | 18.55% | 5.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 341.81% | 31.24% | 1,132.26% | 99.03% | -166.72% |
| Change in Net Operating Assets | -41.71% | -1,533.16% | 578.52% | 586.76% | 118.37% |
| Cash from Operations | 13.84% | -44.92% | 137.96% | 100.32% | 26.94% |
| Capital Expenditure | -- | 100.00% | 58.54% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 58.54% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 6.58% | -- | -- | -90.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 453.10% | 6.58% | -- | -- | -90.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.52% | -5.88% | 144.10% | 59.44% | -237.44% |